Analysis on the current status of targeted drug delivery to tumors
“Targeting” nanoparticles: The constraints of physical laws and physical barriers
Challenges in design and characterization of ligand-targeted drug delivery systems
Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
Challenges in drug delivery to the brain: Nature is against us
Challenges in design of translational nanocarriers
Beyond the imaging: Limitations of cellular uptake study in the evaluation of nanoparticles
Challenges to effective cancer nanotheranostics
Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal models
Tumor heterogeneity and its implication for drug delivery
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
A strategy to improve selectivity and targeting to epithelial-derived cancer cells
Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor
Finding the optimal balance: Challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems
Challenges and opportunities in the advancement of nanomedicines